Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Loss of caveolin-1 promotes endothelial-mesenchymal transition during sepsis: a membrane proteomic study.

Huang X, Pan L, Pu H, Wang Y, Zhang X, Li C, Yang Z.

Int J Mol Med. 2013 Sep;32(3):585-92. doi: 10.3892/ijmm.2013.1432. Epub 2013 Jul 5.

PMID:
23836408
2.

Caveolin-1 opens endothelial cell junctions by targeting catenins.

Kronstein R, Seebach J, Grossklaus S, Minten C, Engelhardt B, Drab M, Liebner S, Arsenijevic Y, Taha AA, Afanasieva T, Schnittler HJ.

Cardiovasc Res. 2012 Jan 1;93(1):130-40. doi: 10.1093/cvr/cvr256. Epub 2011 Sep 29.

PMID:
21960684
3.

Caveolin-1 regulates NF-kappaB activation and lung inflammatory response to sepsis induced by lipopolysaccharide.

Garrean S, Gao XP, Brovkovych V, Shimizu J, Zhao YY, Vogel SM, Malik AB.

J Immunol. 2006 Oct 1;177(7):4853-60.

4.

IL-1β and TGFβ2 synergistically induce endothelial to mesenchymal transition in an NFκB-dependent manner.

Maleszewska M, Moonen JR, Huijkman N, van de Sluis B, Krenning G, Harmsen MC.

Immunobiology. 2013 Apr;218(4):443-54. doi: 10.1016/j.imbio.2012.05.026. Epub 2012 Jun 6.

PMID:
22739237
5.

Caveolin-1 is important for nitric oxide-mediated angiogenesis in fibrin gels with human umbilical vein endothelial cells.

Pan YM, Yao YZ, Zhu ZH, Sun XT, Qiu YD, Ding YT.

Acta Pharmacol Sin. 2006 Dec;27(12):1567-74.

6.

Pathogenesis of pulmonary hypertension: a case for caveolin-1 and cell membrane integrity.

Mathew R.

Am J Physiol Heart Circ Physiol. 2014 Jan 1;306(1):H15-25. doi: 10.1152/ajpheart.00266.2013. Epub 2013 Oct 25. Review.

7.

Vascular endothelial cadherin expression in lung specimens of patients with sepsis-induced acute respiratory distress syndrome and endothelial cell cultures.

Herwig MC, Tsokos M, Hermanns MI, Kirkpatrick CJ, Müller AM.

Pathobiology. 2013;80(5):245-51. doi: 10.1159/000347062. Epub 2013 Apr 27.

8.

Caveolin-1 regulates Rac1 activation and rat pulmonary microvascular endothelial hyperpermeability induced by TNF-α.

Shao M, Yue Y, Sun GY, You QH, Wang N, Zhang D.

PLoS One. 2013;8(1):e55213. doi: 10.1371/journal.pone.0055213. Epub 2013 Jan 30.

9.

Pigment epithelium-derived factor (PEDF) binds to caveolin-1 and inhibits the pro-inflammatory effects of caveolin-1 in endothelial cells.

Matsui T, Higashimoto Y, Taira J, Yamagishi S.

Biochem Biophys Res Commun. 2013 Nov 15;441(2):405-10. doi: 10.1016/j.bbrc.2013.10.074. Epub 2013 Oct 23.

PMID:
24161393
10.

In-depth proteomics approach of secretome to identify novel biomarker for sepsis in LPS-stimulated endothelial cells.

Kwon OK, Lee W, Kim SJ, Lee YM, Lee JY, Kim JY, Bae JS, Lee S.

Electrophoresis. 2015 Dec;36(23):2851-8. doi: 10.1002/elps.201500198. Epub 2015 Sep 13.

PMID:
26257168
11.

Endothelial to mesenchymal transition in the cardiovascular system.

Gong H, Lyu X, Wang Q, Hu M, Zhang X.

Life Sci. 2017 Sep 1;184:95-102. doi: 10.1016/j.lfs.2017.07.014. Epub 2017 Jul 14. Review.

PMID:
28716564
12.

High-molecular-weight hyaluronan is a novel inhibitor of pulmonary vascular leakiness.

Singleton PA, Mirzapoiazova T, Guo Y, Sammani S, Mambetsariev N, Lennon FE, Moreno-Vinasco L, Garcia JG.

Am J Physiol Lung Cell Mol Physiol. 2010 Nov;299(5):L639-51. doi: 10.1152/ajplung.00405.2009. Epub 2010 Aug 13.

13.

Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model.

Ohtsuki S, Ikeda C, Uchida Y, Sakamoto Y, Miller F, Glacial F, Decleves X, Scherrmann JM, Couraud PO, Kubo Y, Tachikawa M, Terasaki T.

Mol Pharm. 2013 Jan 7;10(1):289-96. doi: 10.1021/mp3004308. Epub 2012 Dec 11.

PMID:
23137377
14.

Physiological hydrostatic pressure protects endothelial monolayer integrity.

Müller-Marschhausen K, Waschke J, Drenckhahn D.

Am J Physiol Cell Physiol. 2008 Jan;294(1):C324-32. Epub 2007 Oct 31.

15.

Endothelial nitric oxide synthase is segregated from caveolin-1 and localizes to the leading edge of migrating cells.

Bulotta S, Cerullo A, Barsacchi R, De Palma C, Rotiroti D, Clementi E, Borgese N.

Exp Cell Res. 2006 Apr 1;312(6):877-89. Epub 2006 Jan 20.

PMID:
16427620
16.

Statins prevent tissue factor induction by protease-activated receptors 1 and 2 in human umbilical vein endothelial cells in vitro.

Banfi C, Brioschi M, Lento S, Pirillo A, Galli S, Cosentino S, Tremoli E, Mussoni L.

J Thromb Haemost. 2011 Aug;9(8):1608-19. doi: 10.1111/j.1538-7836.2011.04366.x.

17.

[Effect of lipoxin A(4) on lipopolysaccharide-induced endothelial hyperpermeability in human umbilical vein endothelial cell].

Pang HY, Huang YP, Liu ZJ, Yi P, Gong JM, Hao H, Wu P, Zhou J, Cai L, Huang YJ, Ye DY, Wang ZH.

Zhonghua Fu Chan Ke Za Zhi. 2011 Mar;46(3):199-204. Chinese.

PMID:
21575454
18.

Endothelial-to-mesenchymal transition contributes to cardiac fibrosis.

Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB, Neilson EG, Sayegh MH, Izumo S, Kalluri R.

Nat Med. 2007 Aug;13(8):952-61. Epub 2007 Jul 29.

PMID:
17660828
19.

[Tumor necrosis factor-α promote permeability of human umbilical vein endothelial cells via activating RhoA-ERK1/2 pathway].

Yan CH, Yu HB, Huang MF, Li J, Zhang XL, Han YL.

Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Jun;39(6):531-7. Chinese.

PMID:
21924080
20.

When the endothelium scores an own goal: endothelial cells actively augment metastatic extravasation through endothelial-mesenchymal transition.

Gasparics Á, Rosivall L, Krizbai IA, Sebe A.

Am J Physiol Heart Circ Physiol. 2016 May 1;310(9):H1055-63. doi: 10.1152/ajpheart.00042.2016. Epub 2016 Mar 18. Review.

Supplemental Content

Support Center